Search by Drug Name or NDC

    NDC 57894-0640-04 Tremfya 100 mg/mL Details

    Tremfya 100 mg/mL

    Tremfya is a SUBCUTANEOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Janssen Biotech, Inc.. The primary component is GUSELKUMAB.

    Product Information

    NDC 57894-0640
    Product ID 57894-640_09bab28f-d731-f2e7-e063-6294a90a1b79
    Associated GPIs 9025054200E520 9025054200D220
    GCN Sequence Number 077565
    GCN Sequence Number Description guselkumab SYRINGE 100 MG/ML SUBCUT
    HIC3 L1A
    HIC3 Description ANTIPSORIATIC AGENTS,SYSTEMIC
    GCN 43612
    HICL Sequence Number 044418
    HICL Sequence Number Description GUSELKUMAB
    Brand/Generic Brand
    Proprietary Name Tremfya
    Proprietary Name Suffix n/a
    Non-Proprietary Name Guselkumab
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/mL
    Substance Name GUSELKUMAB
    Labeler Name Janssen Biotech, Inc.
    Pharmaceutical Class Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA761061
    Listing Certified Through 2024-12-31

    Package

    NDC 57894-0640-04 (57894064004)

    NDC Package Code 57894-640-04
    Billing NDC 57894064004
    Package 1 SYRINGE in 1 CARTON (57894-640-04) / 1 mL in 1 SYRINGE
    Marketing Start Date 2017-07-13
    NDC Exclude Flag N
    Pricing Information N/A